| Overview |
| bs-14581R-Biotin |
| EMID1 Polyclonal Antibody, Biotin Conjugated |
| ELISA, IHC-P, IHC-F |
| Rat |
| Human, Mouse, Dog, Cow |
| Specifications |
| Biotin |
| Rabbit |
| KLH conjugated synthetic peptide derived from human EMID1 |
| 351-441/441 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C for 12 months. |
| Target |
| 129080 |
| Q96A84 |
| Cytoplasm |
| AW122071; CO 5; CTA-984G1.2; EMI domain containing 1; EMI domain containing protein 1; EMI domain-containing protein 1; EMI5; EMID 1; Emid1; EMID1_HUMAN; Emilin and multimerin domain containing protein 1; Emilin and multimerin domain-containing protein 1; EMU1; hEmu1; MGC50657; OTTMUSP00000005297; Protein Emu1; Putative emu1; RGD1565846; RP23-338J18.3. |
| Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. |
| Application Dilution |
| ELISA |
1:500-1000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
Powered by Bioz